XML 35 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Reportable Segments
 9 Months Ended
Sep. 30, 2020
Segment Reporting [Abstract]  
Reportable Segments
18. Reportable Segments:
Summarized financial information for the Company’s reportable segments is shown in the following table:
Three months ended
September 30,		Nine months ended
September 30,
2020201920202019
Sales:
Refining Services$107,604 $118,335 $298,727 $341,469 
Catalysts(1)
23,071 25,612 73,143 62,335 
Performance Materials104,574 115,134 274,346 295,095 
Performance Chemicals148,513 167,949 465,433 526,239 
Eliminations(2)
(3,443)(3,229)(10,207)(10,441)
Total$380,319 $423,801 $1,101,442 $1,214,697 
 Segment Adjusted EBITDA:(3)
Refining Services
$44,272 $51,166 $116,451 $133,721 
Catalysts(4)
11,762 31,638 59,741 79,372 
Performance Materials
25,334 25,769 66,148 65,505 
Performance Chemicals
33,919 36,804 108,403 120,642 
 Total Segment Adjusted EBITDA(5)
$115,287 $145,377 $350,743 $399,240 

(1)Excludes the Company’s proportionate share of sales from the Zeolyst International and Zeolyst C.V. joint ventures (collectively, the “Zeolyst Joint Venture”) accounted for using the equity method (see Note 11 to these condensed consolidated financial statements for further information). The proportionate share of sales is $26,552 and $54,414 for the three months ended September 30, 2020 and 2019, respectively. The proportionate share of sales is $99,695 and $123,106 for the nine months ended September 30, 2020 and 2019, respectively.
(2)The Company eliminates intersegment sales when reconciling to the Company’s condensed consolidated statements of income.
(3)The Company defines Adjusted EBITDA as EBITDA adjusted for certain items as noted in the reconciliation below. Management evaluates the performance of its segments and allocates resources based on several factors, of which the primary measure is Adjusted EBITDA. Adjusted EBITDA should not be considered as an alternative to net income as an indicator of the Company’s operating performance. Adjusted EBITDA as defined by the Company may not be comparable with EBITDA or Adjusted EBITDA as defined by other companies.
(4)The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $5,331 for the three months ended September 30, 2020, which includes $76 of equity in net income plus $1,658 of amortization of investment in affiliate step-up and $3,597 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $22,628 for the three months ended September 30, 2019, which includes $17,248 of equity in net income plus $1,658 of amortization of investment in affiliate step-up and $3,722 of joint venture depreciation, amortization and interest.
The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $35,911 for the nine months ended September 30, 2020, which includes $19,882 of equity in net income plus $4,975 of amortization of investment in affiliate step-up and $11,054 of joint venture depreciation, amortization and interest. The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalysts segment is $48,621 for the nine months ended September 30, 2019, which includes $31,548 of equity in net income plus $5,875 of amortization of investment in affiliate step-up and $11,198 of joint venture depreciation, amortization and interest.
(5)Total Segment Adjusted EBITDA differs from the Company’s consolidated Adjusted EBITDA due to unallocated corporate expenses.
A reconciliation of net income attributable to PQ Group Holdings to Segment Adjusted EBITDA is as follows:
Three months ended
September 30,		Nine months ended
September 30,
2020201920202019
Reconciliation of net income attributable to PQ Group Holdings Inc. to Segment Adjusted EBITDA
Net income attributable to PQ Group Holdings Inc.$7,512 $26,713 $23,662 $60,438 
Provision for income taxes11,764 16,718 29,453 39,472 
Interest expense, net18,642 27,697 65,372 84,855 
Depreciation and amortization45,820 44,246 136,313 135,230 
Segment EBITDA83,738 115,374 254,800 319,995 
Joint venture depreciation, amortization and interest3,597 3,722 11,054 11,198 
Amortization of investment in affiliate step-up1,659 1,658 4,975 5,875 
Debt extinguishment costs14,004 1,767 16,517 1,767 
Net (gain) loss on asset disposals(4,453)1,136 3,948 (7,697)
Foreign currency exchange (gain) loss(4,583)4,457 (2,100)5,380 
LIFO expense(751)534 (2,549)10,814 
Transaction and other related costs3,276 670 6,078 1,725 
Equity-based compensation6,137 4,806 18,423 13,576 
Restructuring, integration and business optimization expenses4,595 717 10,215 1,436 
Defined benefit pension plan (benefit) cost378 834 (122)2,379 
Other962 2,009 3,500 4,730 
Adjusted EBITDA108,559 137,684 324,739 371,178 
Unallocated corporate expenses6,728 7,693 26,004 28,062 
Segment Adjusted EBITDA$115,287 $145,377 $350,743 $399,240